Literature DB >> 10082501

Effects of coffee on ambulatory blood pressure in older men and women: A randomized controlled trial.

V Rakic1, V Burke, L J Beilin.   

Abstract

This study assessed the effects of regular coffee drinking on 24-hour ambulatory blood pressure (ABP) in normotensive and hypertensive older men and women. Twenty-two normotensive and 26 hypertensive, nonsmoking men and women, with a mean age of 72.1 years (range, 54 to 89 years), took part in the study. After 2 weeks of a caffeine-free diet, subjects were randomized to continue with the caffeine-free diet and abstain from caffeine-containing drinks or drink instant coffee (5 cups per day, equivalent to 300 mg caffeine per day) in addition to the caffeine-free diet for a further 2 weeks. Change in systolic and diastolic blood pressures (SBP, DBP) determined by 24-hour ambulatory BP monitoring showed significant interactions between coffee drinking and hypertension status. In the hypertensive group, rise in mean 24-hour SBP was greater by 4.8 (SEM, 1.3) mm Hg (P=0.031) and increase in mean 24-hour DBP was higher by 3.0 (1.0) mm Hg (P=0.010) in coffee drinkers than in abstainers. There were no significant differences between abstainers and coffee drinkers in the normotensive group for 24-hour, daytime, or nighttime SBP or DBP. In older men and women with treated or untreated hypertension, ABP increased in coffee drinkers and decreased in abstainers. Restriction of coffee intake may be beneficial in older hypertensive individuals.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10082501     DOI: 10.1161/01.hyp.33.3.869

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  10 in total

Review 1.  Coffee consumption and cardiovascular health: getting to the heart of the matter.

Authors:  Salome A Rebello; Rob M van Dam
Journal:  Curr Cardiol Rep       Date:  2013-10       Impact factor: 2.931

2.  Influence of different doses of coffee on post-exercise blood pressure response.

Authors:  Alesandra A Souza; Raquel Sb Silva; Tais F Silva; Renata L Tavares; Alexandre S Silva
Journal:  Am J Cardiovasc Dis       Date:  2016-11-30

Review 3.  Nonpharmacologic therapy for hypertension: does it really work?

Authors:  Thor Tejada; Alessia Fornoni; Oliver Lenz; Barry J Materson
Journal:  Curr Cardiol Rep       Date:  2006-11       Impact factor: 2.931

4.  Effects of guar gum ingestion on postprandial blood pressure in older adults.

Authors:  A L Jang; S K Hwang; D U Kim
Journal:  J Nutr Health Aging       Date:  2015-03       Impact factor: 4.075

Review 5.  Methylxanthines and the kidney.

Authors:  Hartmut Osswald; Jürgen Schnermann
Journal:  Handb Exp Pharmacol       Date:  2011

Review 6.  Hypertension curriculum review: lifestyle modifications for prevention and treatment of hypertension.

Authors:  Norman M Kaplan
Journal:  J Clin Hypertens (Greenwich)       Date:  2004-12       Impact factor: 3.738

Review 7.  Caffeine and stress: implications for risk, assessment, and management of hypertension.

Authors:  T R Hartley; W R Lovallo; T L Whitsett; B H Sung; M F Wilson
Journal:  J Clin Hypertens (Greenwich)       Date:  2001 Nov-Dec       Impact factor: 3.738

8.  Does consumption of high-caffeine energy drinks affect blood pressure?

Authors:  Debbie L Cohen; Raymond R Townsend
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-10       Impact factor: 3.738

9.  Acute effects of caffeine and cigarette smoking on ventricular long-axis function in healthy subjects.

Authors:  Elisa Giacomin; Elisabetta Palmerini; Piercarlo Ballo; Valerio Zacà; Giovanni Bova; Sergio Mondillo
Journal:  Cardiovasc Ultrasound       Date:  2008-03-04       Impact factor: 2.062

10.  Acute effects of ingesting Java Fittrade mark energy extreme functional coffee on resting energy expenditure and hemodynamic responses in male and female coffee drinkers.

Authors:  Lemuel W Taylor; Colin D Wilborn; Travis Harvey; Jennifer Wismann; Darryn S Willoughby
Journal:  J Int Soc Sports Nutr       Date:  2007-10-05       Impact factor: 5.150

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.